
A phase II study of medroxyprogesterone acetate in patients with hormone receptor negative metastatic breast cancer: translational breast cancer research consortium trial 007
Author(s) -
K.D. Miller,
S.K. Althouse,
L. Nabell,
H Rugo,
LA Carey,
G. Kimmick,
D.R. Jones,
M.J. Merino,
P.S. Steeg
Publication year - 2014
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/naw8-b853
Subject(s) - medroxyprogesterone acetate , breast cancer , metastatic breast cancer , medicine , medroxyprogesterone , oncology , cancer , hormone receptor , hormone